We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Next-Gen Robotic Exoscope Delivers Leap Forward in Optical Performance to Modernize ORs

By HospiMedica International staff writers
Posted on 24 Mar 2023
Print article
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)

The next-generation model of a robotic exoscope, which has undergone extensive clinical validation through thousands of surgical procedures, now offers advanced 4K 3D optics and fluorescence modalities to augment surgical visualization in neurosurgery, ENT, plastics, and the spine.

Modus X is the fourth generation of robotic exoscope from Synaptive Medical Inc. (Toronto, Canada) that allows surgeons to undertake minimally invasive approaches and provides improved ergonomics for a pain-free operative experience. Modus X is part of integrated suite of products from Synaptive that connect clinicians in operating rooms across mid-field MRI, surgical planning and navigation, and surgical visualization. Synaptive’s devices automate critical patient data through each step of surgical intervention to enhance clinical decision-making.

The next-generation Modus X from Synaptive features redesigned 4K 3D optics, 27x magnification, automated image focus, and voice guidance, marking a leap forward in optical performance and robotics to modernize operating rooms. The unique platform allows for fluorescence-guided surgery in order to improve oncological tissue differentiation in real time. The Modus X also features a flexible design to enable field upgrades of Modus V, Synaptive’s third-generation exoscope, which has been installed in 80 hospitals globally. Synaptive has announced the FDA registration for its fourth-generation robotic exoscope, Modus X, making it available in the U.S. and Canada.

“We anticipate these enhanced visualization capabilities will enable surgeons to perform even more effective and precise interventions to the benefit of their patients,” said Cameron Piron, President, and Co-founder of Synaptive Medical. “Through years of interdisciplinary collaboration with our clinical partners, we have arrived at this ultimate platform that pushes the boundaries of surgical visualization.”

Related Links:
Synaptive Medical Inc.

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vibrating Mesh Nebulizer
Aerogen Solo

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.